Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations
about
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisIntrapulmonary pharmacokinetics of linezolidThe path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.Pharmacologic considerations in use and development of antituberculosis drugs.Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.Development of a Multicompartment Permeability-Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs.Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.The importance of clinical pharmacokinetic-pharmacodynamic studies in unraveling the determinants of early and late tuberculosis outcomes
P2860
Q28542435-8C4881F8-D8D3-43AF-B610-D592486BF9EFQ34106719-9C495858-99CE-4EC0-BD22-AB6D0E0F50C5Q35125060-5633F7F2-24B9-465D-8D7A-D6998B45680DQ35166134-5BA21396-6196-4F5C-A387-FFE749DEE59EQ36936597-03E69179-B5F8-4126-A7E6-F5415B792038Q37489476-C570CEA6-D12C-4EF5-91BA-EAF571DE2C83Q37568382-F26D851D-5918-412C-A881-9E35B6C8C0EAQ37869912-95105733-0348-4FC9-835B-62F593A5C962Q37942644-61C27175-548C-471E-A0DB-05B9DABADF46Q38252559-D2607181-4BE2-4D26-AACD-428FD17A12A1Q38865905-C012B806-FED5-4641-BC14-662D7F2D378FQ39632553-C976DBF1-4F18-4711-B9DE-4F7E9B418D91Q39895097-382C08A2-E861-402F-8F9A-B3B66EAAC96BQ40335980-BEBD3AEE-523B-4378-8DCC-92C061A601ADQ40358160-233DAA0D-01EC-404E-AC60-6B9F68C9C8A5Q41996903-F1070FB6-4175-44AF-B6AB-31A153FDBCBFQ46703565-394B2382-66B9-4A7B-A95C-2F4F90582EC8Q57152709-D28B8375-80E3-48C8-921F-C03D2E04D2A0
P2860
Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of AIDS and gender on ...... nary ethambutol concentrations
@ast
Effects of AIDS and gender on ...... nary ethambutol concentrations
@en
type
label
Effects of AIDS and gender on ...... nary ethambutol concentrations
@ast
Effects of AIDS and gender on ...... nary ethambutol concentrations
@en
prefLabel
Effects of AIDS and gender on ...... nary ethambutol concentrations
@ast
Effects of AIDS and gender on ...... nary ethambutol concentrations
@en
P2093
P2860
P1476
Effects of AIDS and gender on ...... nary ethambutol concentrations
@en
P2093
P2860
P304
P356
10.1128/AAC.45.10.2891-2896.2001
P407
P577
2001-10-01T00:00:00Z